# Prostate Cancer Foundation of Australia

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/prostate-cancer-foundation-of-australia/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 80.7 |
| Citations | 45,512 |
| City | Sydney |
| Country | AU |
| Description | Prostate Cancer Foundation of Australia is a research organisation in Sydney, AU. OpenAlex records 683 works and 45,512 citations for it. |
| Homepage | http://www.prostate.org.au/ |
| OpenAlex ID | https://openalex.org/I1293939003 |
| Region | New South Wales |
| ROR ID | https://ror.org/02kna3n95 |
| Type | nonprofit |
| Wikidata ID | https://www.wikidata.org/wiki/Q17009886 |
| Works | 683 |

## University papers

Showing 12 of 13.

- [Integrative Genomic Profiling of Human Prostate Cancer](https://scholariq.org/papers/integrative-genomic-profiling-of-human-prostate-cancer/)
- [The Molecular Taxonomy of Primary Prostate Cancer](https://scholariq.org/papers/the-molecular-taxonomy-of-primary-prostate-cancer/)
- [Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study](https://scholariq.org/papers/prostate-specific-membrane-antigen-pet-ct-in-patients-with-high-risk-prostate/)
- [<i>MET</i> amplification occurs with or without <i>T790M</i> mutations in <i>EGFR</i> mutant lung tumors with acquired resistance to gefitinib or erlotinib](https://scholariq.org/papers/i-met-i-amplification-occurs-with-or-without-i-t790m-i-mutations-in-i-egfr-i/)
- [Systematic Review and Meta-analysis of Studies Reporting Urinary Continence Recovery After Robot-assisted Radical Prostatectomy](https://scholariq.org/papers/systematic-review-and-meta-analysis-of-studies-reporting-urinary-continence/)
- [Gene expression–based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study](https://scholariq.org/papers/gene-expression-based-survival-prediction-in-lung-adenocarcinoma-a-multi-site/)
- [Sensitivity, Specificity, and Predictors of Positive 68 Ga–Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer: A Systematic Review and Meta-analysis](https://scholariq.org/papers/sensitivity-specificity-and-predictors-of-positive-68-ga-prostate-specific/)
- [Gallium-68 Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer—Updated Diagnostic Utility, Sensitivity, Specificity, and Distribution of Prostate-specific Membrane Antigen-avid Lesions: A Systematic Review and Meta-analysis](https://scholariq.org/papers/gallium-68-prostate-specific-membrane-antigen-positron-emission-tomography-in/)
- [Systematic Review and Meta-analysis of Studies Reporting Potency Rates After Robot-assisted Radical Prostatectomy](https://scholariq.org/papers/systematic-review-and-meta-analysis-of-studies-reporting-potency-rates-after/)
- [Systematic Review and Meta-analysis of Perioperative Outcomes and Complications After Robot-assisted Radical Prostatectomy](https://scholariq.org/papers/systematic-review-and-meta-analysis-of-perioperative-outcomes-and-complications/)
- [The Additive Diagnostic Value of Prostate-specific Membrane Antigen Positron Emission Tomography Computed Tomography to Multiparametric Magnetic Resonance Imaging Triage in the Diagnosis of Prostate Cancer (PRIMARY): A Prospective Multicentre Study](https://scholariq.org/papers/the-additive-diagnostic-value-of-prostate-specific-membrane-antigen-positron/)
- [Association of survival and disease progression with chromosomal instability: A genomic exploration of colorectal cancer](https://scholariq.org/papers/association-of-survival-and-disease-progression-with-chromosomal-instability-a/)

## University top topics

Showing 8 of 25.

- [Prostate Cancer Diagnosis and Treatment](https://scholariq.org/topics/prostate-cancer-diagnosis-and-treatment/)
- [Prostate Cancer Treatment and Research](https://scholariq.org/topics/prostate-cancer-treatment-and-research/)
- [Cancer survivorship and care](https://scholariq.org/topics/cancer-survivorship-and-care/)
- [Global Cancer Incidence and Screening](https://scholariq.org/topics/global-cancer-incidence-and-screening/)
- [Radiopharmaceutical Chemistry and Applications](https://scholariq.org/topics/radiopharmaceutical-chemistry-and-applications/)
- [Urinary Bladder and Prostate Research](https://scholariq.org/topics/urinary-bladder-and-prostate-research/)
- [Patient-Provider Communication in Healthcare](https://scholariq.org/topics/patient-provider-communication-in-healthcare/)
- [Dementia and Cognitive Impairment Research](https://scholariq.org/topics/dementia-and-cognitive-impairment-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.